{
  "Variants Include": [
    {
      "Gene": "PDCD1",
      "variants": [
        {
          "HGVS": "(NM_002364598.3:c.78A>G, NM_002364598.4:c.78T>A)",
          "cDNA Change": {
            "transcript": "NM_002364598",
            "ref": "G",
            "alt": "A or T",
            "position": "78"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "G or T",
            "position": "(78-106)"
          },
          "Description in input context": "The variant leads to a frameshift mutation."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005947"
  },
  "Experiment Method": [
    {
      "Assay Method": "2-D Difference Gel Electrophoresis (2-D DGE)",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "The experiment was conducted using the HEK293 cell line."
      },
      "Readout type": "Qualitative/Quantitative (Western Blot)",
      "Readout description": [
        {
          "Variant": "(NM_002364598.3:c.78A>G, NM_002364598.4:c.78T>A)",
          "Conclusion": "Altered",
          "Molecular Effect": "frameshift mutation leading to truncated protein",
          "Result Description": " western blot analysis showed reduced expression of OXPHOS proteins (HSPA9, NDUFS1, DLAT, and ATP5A1)."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Repeated experiments were conducted for consistency."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in duplicate to ensure reproducibility."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "The experiment included controls with normal cDNA to confirm specificity."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Negative controls were used to assess nonspecific binding or non-specific cleavage."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA and independent t-test for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression greater than 80% on day 7.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression less than 50% on day 7.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}